Doxirut-50: Cefpodoxime 50mg Dry Syrup for Pediatric Infections Product Overview Doxirut-50 is a premium pediatric antibiotic formulation containing Cefpodoxime Proxetil 50mg in dry syrup form, manufactured by Medroots Biopharma India Pvt Ltd. This third-generation cephalosporin antibiotic is specifically designed for treating bacterial infections in children across India. Key Product Information Brand Name: Doxirut-50 Generic Name: Cefpodoxime Proxetil Strength: 50mg per 5ml (when reconstituted) Formulation: Dry Syrup for Oral Suspension Manufacturer: Medroots Biopharma India Pvt Ltd Availability: Pan India Distribution Category: Prescription Antibiotic for Pediatric Use What is Cefpodoxime 50mg Dry Syrup? Cefpodoxime is a broad-spectrum, third-generation cephalosporin antibiotic that effectively treats various bacterial infections in children. Doxirut-50 dry syrup provides a convenient, palatable formulation that ensures accurate dosing and improved compliance in pediatric patients. Pediatric Uses and Indications Doxirut-50 is prescribed for treating the following bacterial infections in children: Respiratory Tract Infections Acute otitis media (middle ear infections) Pharyngitis and tonsillitis Community-acquired pneumonia Acute bronchitis Sinusitis Skin and Soft Tissue Infections Cellulitis Impetigo Skin structure infections Wound infections Urinary Tract Infections Uncomplicated urinary tract infections Cystitis Pyelonephritis (when appropriate) Other Infections Gonorrhea (in adolescents) Cervicitis and urethritis Dosage and Administration Recommended Pediatric Dosing Age 2 months to 12 years: 10mg/kg/day divided into two doses Maximum daily dose: 400mg Duration: Typically 5-10 days as prescribed by physician Administration: With or without food Reconstitution Instructions Add specified amount of boiled and cooled water Shake well until completely dissolved Store reconstituted suspension in refrigerator Use within 14 days of reconstitution Shake well before each use Key Benefits of Doxirut-50 Clinical Advantages Broad-spectrum coverage against gram-positive and gram-negative bacteria High bioavailability ensuring effective therapeutic levels Twice-daily dosing improving medication compliance Pleasant taste for better pediatric acceptance Stable formulation with extended shelf life Safety Profile Well-tolerated in pediatric populations Lower incidence of gastrointestinal side effects Minimal drug interactions Safe for use in children with penicillin allergies (with proper medical supervision) Mechanism of Action Cefpodoxime works by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs). This bactericidal action effectively eliminates susceptible bacteria, making it highly effective against common pediatric pathogens including: Streptococcus pneumoniae Haemophilus influenzae Moraxella catarrhalis Staphylococcus aureus Escherichia coli Klebsiella pneumoniae Why Choose Doxirut-50? Quality Assurance Manufactured by Medroots Biopharma India Pvt Ltd Strict quality control standards WHO-GMP certified manufacturing facility Consistent potency and purity Healthcare Provider Benefits Proven efficacy in pediatric infections Comprehensive bacterial coverage Convenient twice-daily dosing Excellent safety profile Cost-effective treatment option Parent and Child Benefits Pleasant-tasting formulation Easy-to-administer liquid form Rapid symptom relief Shorter treatment duration Minimal side effects Storage and Handling Before reconstitution: Store below 25°C in dry place After reconstitution: Refrigerate at 2-8°C Shelf life: 24 months from manufacturing date Reconstituted stability: 14 days when refrigerated Keep out of reach of children Important Safety Information Contraindications Hypersensitivity to cefpodoxime or other cephalosporins Severe renal impairment History of cephalosporin-associated colitis Precautions Use with caution in penicillin-allergic patients Monitor renal function in prolonged therapy Complete full course as prescribed Inform healthcare provider of all concurrent medications Common Side Effects Mild gastrointestinal upset Diarrhea Nausea Headache Skin rash (rare) Prescription Information Doxirut-50 is a prescription-only medicine that should be used under medical supervision. Healthcare providers should: Confirm bacterial infection before prescribing Consider local resistance patterns Ensure appropriate dosing based on child's weight and age Monitor treatment response Educate parents on proper administration Availability Across India Doxirut-50 is available through authorized pharmaceutical distributors and pharmacies across all states and union territories of India. The product maintains consistent quality and availability through Medroots Biopharma's extensive distribution network. Frequently Asked Questions Can Doxirut-50 be given with food? Yes, Cefpodoxime can be administered with or without food. Taking with food may help reduce stomach upset. What if a dose is missed? Give the missed dose as soon as remembered, unless it's almost time for the next dose. Never double the dose. How quickly does Doxirut-50 work? Most children show improvement within 48-72 hours. Complete the full course even if symptoms improve. Is Doxirut-50 safe for infants? Consult your pediatrician for appropriate use in children under 2 months of age. Contact Information For medical inquiries and product information: Medroots Biopharma India Pvt Ltd Available through authorized medical representatives Pharmacovigilance reporting available Healthcare provider support services contact-no-6284828066